Skip to content

Hepatic haemodynamics in porto-sinusoidal vascular disease (PSVD): a multiscale CFD study

Hepatic haemodynamics in porto-sinusoidal vascular disease (PSVD): a multiscale CFD study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500115595
Enrollment
Unknown
Registered
2025-12-29
Start date
2025-05-01
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Porto-sinusoidal vascular disease

Interventions

Observation group:None

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. According to the results of the liver biopsy pathology, the absence of cirrhosis is confirmed. Subsequently, the diagnosis can be made if any one of the following three criteria is met: (1) The presence of a specific manifestation of portal hypertension; (2) The presence of a specific histological lesion of PSVD; (3) The presence of one non-specific manifestation of portal hypertension and one non-specific histological lesion of PSVD. Since the purpose of liver biopsy is to exclude cirrhosis and detect subtle and unevenly distributed PSVD histological lesions, the length of the biopsy specimen must be >=20 mm and contain >=10 complete portal tracts.

Exclusion criteria

Exclusion criteria: 1. Diseases affecting the hepatic veins (such as Budd-Chiari syndrome); 2. Diseases causing microvascular damage (such as hepatic nodular disease, congenital hepatic fibrosis, or sinusoidal obstruction syndrome); 3. No liver biopsy performed or liver biopsy pathology confirming cirrhosis; 4. No upper abdominal CTA and liver Doppler ultrasound examination.

Design outcomes

Primary

MeasureTime frame
Portal pressure gradient, PPG;hepatic venous pressure gradient,HVPG;Wall shear stress, WSS;Shunt volume;Recirculation zone;Energy loss;

Countries

China

Contacts

Public ContactHao Wu

West China Hospital, Sichuan University

hxxhwh@163.com+86 189 8060 1287

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026